154 related articles for article (PubMed ID: 17198523)
1. Diet, cholesterol metabolism, and Alzheimer's disease: Apolipoprotein E as a possible link?
Panza F; Capurso C; D'Introno A; Colacicco AM; Del Parigi A; Seripa D; Pilotto A; Capurso A; Solfrizzi V
J Am Geriatr Soc; 2006 Dec; 54(12):1963-5. PubMed ID: 17198523
[No Abstract] [Full Text] [Related]
2. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
[TBL] [Abstract][Full Text] [Related]
3. Fatty acids, lipid metabolism and Alzheimer pathology.
Hooijmans CR; Kiliaan AJ
Eur J Pharmacol; 2008 May; 585(1):176-96. PubMed ID: 18378224
[TBL] [Abstract][Full Text] [Related]
4. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
[TBL] [Abstract][Full Text] [Related]
5. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
6. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of Alzheimer's disease: an update.
Brouwers N; Sleegers K; Van Broeckhoven C
Ann Med; 2008; 40(8):562-83. PubMed ID: 18608129
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
[TBL] [Abstract][Full Text] [Related]
9. Traumatic brain injury and Alzheimer's disease: a review.
Van Den Heuvel C; Thornton E; Vink R
Prog Brain Res; 2007; 161():303-16. PubMed ID: 17618986
[TBL] [Abstract][Full Text] [Related]
10. Amyloid excess in Alzheimer's disease: what is cholesterol to be blamed for?
Ledesma MD; Dotti CG
FEBS Lett; 2006 Oct; 580(23):5525-32. PubMed ID: 16814780
[TBL] [Abstract][Full Text] [Related]
11. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
[TBL] [Abstract][Full Text] [Related]
12. Advances in genetic testing for Alzheimer's disease.
Howard KL; Filley CM
Rev Neurol Dis; 2009; 6(1):26-32. PubMed ID: 19367221
[TBL] [Abstract][Full Text] [Related]
13. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk.
Qureischie H; Heun R; Lütjohann D; Popp J; Jessen F; Ledschbor-Frahnert C; Thiele H; Maier W; Hentschel F; Kelemen P; Kölsch H
Brain Res; 2008 Sep; 1232():1-6. PubMed ID: 18680734
[TBL] [Abstract][Full Text] [Related]
14. Animal models of Alzheimer's disease and frontotemporal dementia.
Götz J; Ittner LM
Nat Rev Neurosci; 2008 Jul; 9(7):532-44. PubMed ID: 18568014
[TBL] [Abstract][Full Text] [Related]
15. Epistasis in sporadic Alzheimer's disease.
Combarros O; Cortina-Borja M; Smith AD; Lehmann DJ
Neurobiol Aging; 2009 Sep; 30(9):1333-49. PubMed ID: 18206267
[TBL] [Abstract][Full Text] [Related]
16. Fat intake, antioxidants and Alzheimer's disease.
Health News; 2003 Apr; 9(4):7-8. PubMed ID: 12710395
[No Abstract] [Full Text] [Related]
17. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
[TBL] [Abstract][Full Text] [Related]
18. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype.
Cho SW; Kang JY; Park YK; Paek YM; Choi TI
Nutr Res; 2009 Aug; 29(8):542-50. PubMed ID: 19761888
[TBL] [Abstract][Full Text] [Related]
19. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
Hasegawa T
Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer disease--when and why?
Price DL; Sisodia SS; Borchelt DR
Nat Genet; 1998 Aug; 19(4):314-6. PubMed ID: 9697686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
